BioAge Labs logo

BioAge Labs

BIOA | NASDAQ
Chart Builder DCF Calculator
$5.22
-$0.33 (-5.95%)
At close: Nov 16, 2026, 4:00 PM ET
$5.21
-$0.01 (-0.19%)
After-hours: Nov 16, 2026, 7:30 PM ET
-5.95%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
38
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #580/1021 (Top 57%)

Key Statistics

Market Data

Market Cap $239.66M
1D Range
5.08 5.64
52W Range
4.84 25.10

Valuation (TTM)

PE -2.05
PB 0.69
EV/EBITDA 0.37

Valuation (NTM)

Forward PE N/A
Forward PEG -0.15
Price Target $21.00
Loading financial charts...

Profile

BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases. The company’s technology platform and differentiated human datasets that ...

Sector Healthcare
Industry Biotechnology
Employees 61
IPO Date Sep 26, 2024
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 5, 2026
EPS
-$0.73
Miss -7.35%
REV
$298K
Miss -79.83%
Next Earnings
Mar 23, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
7
Consensus
Buy
Price Target
$21.00
Upside
+302.30%
Buy (6)
Hold (1)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.